Sign in

Back to the bill

88th General Assembly · Iowa Funnel one-pager · Tuesday, November 10, 2026

SSB 3162: SSB 3162

Became SF 2342 · Its progress continues under the new number.

Sponsors

Not listed

Cost

See the fiscal note

The fiscal impact of SF 2342 for shifting the share of costs associated with diagnostic breast cancer examinations from Plan members to the Plan is approximately $122,000 in FY 2021 and $129,000 in FY 2022. 1% of the total amount paid by the State of Iowa Plan…

Senate subcommittee · named February 13, 2020

  • Sen. Jim Carlin (R)
  • Sen. Thomas A. Greene (R)
  • Sen. Liz Mathis (D)

Lobbying · 2 for, 0 against

For: Genentech, Inc., A Member of the Roche Group; Iowa Army of Pink

In plain words

  1. February 12, 2020Filed in the Senate and sent to the Human Resources committee
  2. February 13, 2020Senate subcommittee named: Carlin, Greene and Mathis
  3. February 18, 2020Subcommittee recommended passing it
  4. February 19, 2020Approved by the Senate committee, and given a new number: SF 2342

From public records at legis.iowa.gov, compiled by Iowa Funnel (iowafunnel.com), an independent, nonpartisan site. Current as of Tuesday, November 10, 2026. https://iowafunnel.com/bills/88/SSB3162